TORONTO, Feb. 11, 2021 (GLOBE NEWSWIRE) — Skylight Health Group Inc (TSXV:SHG; OTCQX: SHGFF) (“Skylight Health” or the “Company”), has been invited to present at the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference that will be held on February 17-19, 2021.
BTIG has 3,000+ institutional and corporate clients, with global locations across the US, Europe, Asia and Australia. The firm specializes in investment banking, sales & trading, and equity research. BTIG expects host nearly 100 corporate management teams throughout the three-day event which includes thematic panels, company presentations, fireside chats and one-on-one meetings.
Prad Sekar, Co-Founder and CEO of Skylight Health will present at the following time:
Thursday, February 18, 2021
2:30 – 2:55 PM ET
A video playback of the presentation will be made available in the News section of the Company’s website once it is made available to the Company.
Thematic panel discussion topics include:
- Sustainability of High-Growth Health Tech
- Infectious Disease Testing Opportunities Beyond the Pandemic
- Transforming Cost and Quality Through Virtual Care and Deep Data
- Where are We Headed in Glaucoma Basis Devices and Drug-Device Combinations?
- How Robotics is Reshaping our Practices: Perspective from Musculoskeletal Physicians
- Are Accommodative and Adjustable Lenses Set to Become the Standard of Care?
- Repeat Patient Monitoring Using Novel MRD-Based Liquid Biopsy Assays
- The Role of Liquid Biopsy Assays in Early Cancer Detection
- The Competition Heats Up: The Latest Diabetes Technology
- Current and Emerging Interventional Cardiology Devices
- VC Investors’ Perspectives on MedTech
- Single Cell/Spatially Resolved Omics
“Our 2021 conference provides an opportunity for participants to interact with some of the most innovative healthcare companies and astute investors in the world. We look forward to inspiring insightful conversations about the future of the industry that will offer our clients new perspectives,” noted David Lenchus, Director of Research at BTIG.
BTIG’s Corporate Access program hosts client events across the consumer, energy, financials, healthcare, real estate, shipping as well as technology, media and telecommunications sectors.
For more information about the conference, email [email protected]. Please note that participants must be pre-registered to attend. To access BTIG insights, contact a BTIG representative or login to www.btigresearch.com.
BTIG is a global financial services firm specializing in institutional trading, investment banking, research and related brokerage services. With an extensive global footprint and more than 650 employees, BTIG, LLC and its affiliates operate out of 18 cities throughout the U.S., and in Europe, Asia and Australia. BTIG offers execution, expertise and insights for equities, equity derivatives, ETFs and fixed income, currency and commodities (futures, interest rates, credit, and convertible and preferred securities). The firm’s core capabilities include global execution, portfolio, electronic and outsource trading, transition management, investment banking, prime brokerage, capital introduction, corporate access, research and strategy, commission management and more. Disclaimer: https://www.btig.com/disclaimer.
To learn more about BTIG, visit www.btig.com
About Skylight Health Group
Skylight Health Group (TSXV:SHG; OTCQX:SHGFF) is a healthcare services and technology company, working to positively impact patient health outcomes. The Company operates a US multi-state health network that comprises of physical multi-disciplinary medical clinics providing a range of services from primary care, sub-specialty, allied health and laboratory/diagnostic testing. The Company owns and operates a proprietary electronic health record system that supports the delivery of care to patients via telemedicine and other remote monitoring system integrations. With a patient roster of over 155,000 patients, the Company’s operations servicing 16 states and continues to expand in services and locations both organically and by way of strategic acquisitions.
The Company primarily operates a traditional insurable fee-for-service model contracting with Medicare, Medicaid and other Commercial Payors. The Company also offers a disruptive subscription-based telemedicine service for the un/under-insured population who have limited access to urgent care due to cost.
For more information, please visit www.skylighthealthgroup.com or contact:
Currency Usage, Cautionary and Forward-Looking Statements
All currency contained in this Press Release represent Canadian Dollars unless otherwise stated.
Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in Skylight Health’s filings with Canadian securities regulators. When used in this news release, words such as “will, could, plan, estimate, expect, intend, may, potential, believe, should,” and similar expressions, are forward-looking statements.
Forward-looking statements may include, without limitation, statements regarding the Company’s unaudited financial results and projected growth.
Financial forecasts in this release are based on the current revenue run rate of Skylight Health, all of its recently completed acquisitions, and its pending acquisitions. This forecast is subject to the closing of any and all pending acquisitions, and successful integration of all its current and future acquisitions without any loss or interruptions of revenues during the integration and transition process. The Company may revise this forecast from time to time and investors should not solely rely on this forward-looking guidance when making an investment decision.
Although Skylight Health has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: the ability of Skylight Health to execute on its business strategy, continued revenue growth in accordance with management’s expectations, operating expenses continuing in accordance with management expectations, dependence on obtaining regulatory approvals; Skylight Health being able to find, complete and effectively integrate target acquisitions; change in laws relating to health care regulation; reliance on management; requirements for additional financing; competition; hindering market growth or other factors that may not currently be known by the Company.
There can be no assurance that such information will prove to be accurate or that management’s expectations or estimates of future developments, circumstances or results will materialize. As a result of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events.
Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this release. Skylight Health disclaims any intention or obligation to update or revise such information, except as required by applicable law, and Skylight Health does not assume any liability for disclosure relating to any other company mentioned herein.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.